title: [Efficiency of cytoflavin in the treatment of somatoform disorders].
abstract: OBJECTIVE
  To study the efficacy of cytoflavin in patients with somatoform disorders (SD).
  
  
  METHODS
  The study included 60 patients with SD, aged from 27 to 43 years. The efficacy was assessed by the results of psychological and neurophysiological examinations.
  
  
  CONCLUSIONS
  The higher efficacy of cytoflavin (the improvement of patient's condition in 63,3% of cases) compared to that of ethylmethylhydroxypyridine succinate (56,7% of cases) was found. Patient's state was more stable after treatment with cytoflavin.
authors.affiliation: Institute of Human Brain Russian Academy of Sciences, St. Petersburg.
authors.forename: L S
authors.initials: LS
authors.lastname: Chutko
authors.affiliation: Institute of Human Brain Russian Academy of Sciences, St. Petersburg.
authors.forename: S Y
authors.initials: SY
authors.lastname: Surushkina
authors.affiliation: Institute of Human Brain Russian Academy of Sciences, St. Petersburg.
authors.forename: E A
authors.initials: EA
authors.lastname: Yakovenko
authors.affiliation: Institute of Human Brain Russian Academy of Sciences, St. Petersburg.
authors.forename: T I
authors.initials: TI
authors.lastname: Anisimova
authors.affiliation: Kirov Military Medical Academy, St. Petersburg, Russia.
authors.forename: S M
authors.initials: SM
authors.lastname: Prokopenko
mesh_terms: D000328:Adult; D004338:Drug Combinations; D005260:Female; D005486:Flavin Mononucleotide / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007290:Inosine Diphosphate / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009483:Neuropsychological Tests; D009536:Niacinamide / Q000009:adverse effects / Q000627:therapeutic use*; D013001:Somatoform Disorders / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D013386:Succinates / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D004338:Drug Combinations; D018696:Neuroprotective Agents; D013386:Succinates; C507879:cytoflavin; D009536:Niacinamide; D005486:Flavin Mononucleotide; D007290:Inosine Diphosphate